Thousands have benefited from screening following the discovery of the BRCA2 gene. “One breast cancer gene, BRCA1, had already been found and it was unlikely there would be a second, I was told,” Stratton told the Observer last week. We had discovered a new breast cancer gene and, for good measure, we had found out where it lay on the human genome. “This group was backed by the company Myriad Genetics who had found the first breast cancer gene, BRCA1, and who had taken out a patent on it. It had the experience and also plenty of funds to back its search for another cancer gene.

Source: The Guardian January 10, 2021 08:26 UTC